The post 21Shares files for Injective ETF amid growing institutional interest appeared on BitcoinEthereumNews.com. Key Takeaways 21Shares has filed for a new ETF focusing on Injective, a blockchain protocol designed for global finance infrastructure. The filing highlights the growing institutional interest in integrating digital assets into traditional finance portfolios. 21Shares, a major issuer of crypto-focused exchange-traded products, filed today for a new ETF targeting Injective, a blockchain protocol positioned as infrastructure for global finance with features like high-performance consensus and native financial primitives. The filing represents another expansion of institutional crypto investment products as traditional finance continues integrating digital assets. 21Shares recently expanded listings to UK retail investors on major exchanges. The company has been actively introducing new exchange-traded products for various digital assets, including those focused on decentralized computing and artificial intelligence. 21Shares has collaborated with foundations and exchanges to launch endorsed products, such as those tied to meme coins and scalable Web3 architectures. The move signals broader integration of digital assets into mainstream portfolios as entities like 21Shares work to simplify access to blockchain ecosystems through regulated investment vehicles. Source: https://cryptobriefing.com/21shares-injective-etf-filing-institutional-interest/The post 21Shares files for Injective ETF amid growing institutional interest appeared on BitcoinEthereumNews.com. Key Takeaways 21Shares has filed for a new ETF focusing on Injective, a blockchain protocol designed for global finance infrastructure. The filing highlights the growing institutional interest in integrating digital assets into traditional finance portfolios. 21Shares, a major issuer of crypto-focused exchange-traded products, filed today for a new ETF targeting Injective, a blockchain protocol positioned as infrastructure for global finance with features like high-performance consensus and native financial primitives. The filing represents another expansion of institutional crypto investment products as traditional finance continues integrating digital assets. 21Shares recently expanded listings to UK retail investors on major exchanges. The company has been actively introducing new exchange-traded products for various digital assets, including those focused on decentralized computing and artificial intelligence. 21Shares has collaborated with foundations and exchanges to launch endorsed products, such as those tied to meme coins and scalable Web3 architectures. The move signals broader integration of digital assets into mainstream portfolios as entities like 21Shares work to simplify access to blockchain ecosystems through regulated investment vehicles. Source: https://cryptobriefing.com/21shares-injective-etf-filing-institutional-interest/

21Shares files for Injective ETF amid growing institutional interest

2025/10/21 00:58
1분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Key Takeaways

  • 21Shares has filed for a new ETF focusing on Injective, a blockchain protocol designed for global finance infrastructure.
  • The filing highlights the growing institutional interest in integrating digital assets into traditional finance portfolios.

21Shares, a major issuer of crypto-focused exchange-traded products, filed today for a new ETF targeting Injective, a blockchain protocol positioned as infrastructure for global finance with features like high-performance consensus and native financial primitives.

The filing represents another expansion of institutional crypto investment products as traditional finance continues integrating digital assets. 21Shares recently expanded listings to UK retail investors on major exchanges.

The company has been actively introducing new exchange-traded products for various digital assets, including those focused on decentralized computing and artificial intelligence. 21Shares has collaborated with foundations and exchanges to launch endorsed products, such as those tied to meme coins and scalable Web3 architectures.

The move signals broader integration of digital assets into mainstream portfolios as entities like 21Shares work to simplify access to blockchain ecosystems through regulated investment vehicles.

Source: https://cryptobriefing.com/21shares-injective-etf-filing-institutional-interest/

시장 기회
Major 로고
Major 가격(MAJOR)
$0.0618
$0.0618$0.0618
+0.11%
USD
Major (MAJOR) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!